𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Optimization in Drug Discovery: In Vitro Methods

✍ Scribed by Gary W. Caldwell, Becki Hasting, John A. Masucci (auth.), Gary W. Caldwell, Zhengyin Yan (eds.)


Publisher
Humana Press
Year
2014
Tongue
English
Leaves
596
Series
Methods in Pharmacology and Toxicology
Edition
2
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis


Thoroughly revised and updated, Optimization in Drug Discovery: In Vitro Methods, Second Edition presents a wide spectrum of in vitro assays including formulation, plasma binding, absorption and permeability, cytochrome P450 (CYP) and UDP-glucuronosyltransferases (UGT) metabolism, CYP inhibition and induction, drug transporters, drug-drug interactions via assessment of reactive metabolites, genotoxicity, and chemical and photo-mutagenicity assays. Written for the Methods in Pharmacology and Toxicology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible protocols, and tips on troubleshooting and avoiding known pitfalls. Expert authors have developed and utilized these in vitro assays to achieve β€œdrug-like” characteristics in addition to efficacy properties and good safety profiles of drug candidates.

Comprehensive and up-to-date, Optimization in Drug Discovery: In Vitro Methods, Second Edition aims to guide researchers down the difficult path to successful drug discovery and development.

✦ Table of Contents


Front Matter....Pages i-xvii
Back Matter....Pages 1-20
....Pages 21-37

✦ Subjects


Pharmacology/Toxicology


πŸ“œ SIMILAR VOLUMES


Optimization in Drug Discovery: In Vitro
✍ Yushen Guo, Hong Shen (auth.), Zhengyin Yan PhD, Gary W. Caldwell PhD (eds.) πŸ“‚ Library πŸ“… 2004 πŸ› Humana Press 🌐 English

<p>Although parallel synthesis combined with high-throughput screening has made it easier to generate highly potent drug candidates, many of these compounds never make the grade because they either prove to be unsafe or lack the necessary physicochemical and pharmacokinetic properties. In Optimizati

Optimization in drug discovery: in vitro
✍ Caldwell, Gary;Yan, Zhengyin πŸ“‚ Library πŸ“… 2004 πŸ› Humana Press 🌐 English

Isothermal titration calorimetry characterization of drug-binding energetics to blood proteins / Gary W. Caldwell and Zhengyin Yan -- Metabolic stability assessed by liver microsomes and hepatocytes / David C. Ackley, Kevin T. Rockich, and Timothy R. Baker -- In vitro drug metabolite profiling using

Optimization in Drug Discovery
✍ Zhengyin Yan, Gary Caldwell (Eds.) πŸ“‚ Library πŸ“… 2004 πŸ› Springer-Verlag New York, LLC 🌐 English

A panel of researchers and experts from leading universities and major pharmaceutical companies from all over the world systematically describe cutting-edge experimental protocols for the early in vitro evaluation of new chemical entities (NCE). These readily reproducible assays measure such critica

Optimization in Drug Discovery
✍ Yan Z., Caldwell G. (eds.) πŸ“‚ Library πŸ“… 2004 πŸ› Humana 🌐 English

A panel of researchers and experts from leading universities and major pharmaceutical companies from all over the world systematically describe cutting-edge experimental protocols for the early in vitro evaluation of new chemical entities (NCE). These readily reproducible assays measure such critica

High-throughput lead optimization in dru
✍ Tushar Kshirsagar πŸ“‚ Library πŸ“… 2008 πŸ› CRC Press 🌐 English

<b>A Single Source on Parallel Synthesis for Lead Optimization <p>The end of the previous millennium saw an explosion in the application of parallel synthesis techniques for making compounds for high-throughput screening. Over time, it became clear that more thought in the design phase of library

Fragment-Based Methods in Drug Discovery
✍ Anthony E. Klon (eds.) πŸ“‚ Library πŸ“… 2015 πŸ› Humana Press 🌐 English

<p><p>This volume covers the techniques necessary for a successful fragment-based drug design project, beginning from defining the problem in terms of preparing the protein model, identifying potential binding sites, and the consideration of various candidate fragments for simulation. The second par